ALF promotes education, advocacy, support services and research for the prevention, treatment and cure of liver disease. ALF Mid-America provides a wide variety of these services including information and referral, education programs, support groups, exciting fundraising events, and an array of volunteer opportunities.
For help with issues related to liver disease, please contact our Help Center by using the Live Chat feature at the bottom of your browser window or call us at (800) 465-4837 Monday through Friday 9 am to 5 pm Eastern Time or by email at info@liverfoundation.org.
Missouri Department of Health and Senior Services
Support groups provide a place for individuals affected by a similar condition or circumstance to provide and receive support and share their experiences.
Not all support groups are facilitated by a medical professional. Some support groups are facilitated by 3rd party organizations and individuals in this region.
ALF also has identified virtual online support groups you can take advantage of by visiting this page.
St. Louis
Barnes-Jewish Hospital
Center for Advanced Medicine Building
4921 Parkview Place
3rd Floor, Farrell Conference Room #2
St. Louis, MO 63110
Not an ALF-affiliated support group
Meets: Third Wednesday of each month, 6:30 – 8 PM
Phone: 314-747-9963
Kate Beermann, LCSW
Join the PBC Support Group Facebook page for weekly discussions and presentations on different prominent topics in PBC!
Contact: Megan Glynn
Phone: 646-737-9402 | More Information
Click here to join the PBC Support Group facebook page to learn about PBC resouces, information, and gain community support!
The live discussions and chat sessions will occur every Wednesday from 9am-10am and 7pm-8pm. The information and discussions will remain posted for those who are unable to attend live!
Participating in a clinical trial is a great way to contribute to curing, preventing and treating liver disease and its complications. Start your search here to find clinical trials that need people like you.
Protocol
THIS TRIAL WILL BEGIN IN APRIL, 2021
Title
Phase 3 Semaglutide in NASH (ESSENCE)
Area
Liver
Indication
Current diagnosis of fatty liver disease with fibrosis
Treatment
Injectable medication for NASH
Notify
Malana Kanallakan
314- 328-6466
Protocol
THIS TRIAL IS CURRENTLY IN RECESS DUE TO COVID-19
Title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (AURORA)
Area
Liver
Indication
Current diagnosis of fatty liver disease with fibrosis
Treatment
Oral medication for NASH
Notify
Malana Kanallakan
314- 328-6466
Protocol
THIS TRIAL IS CURRENTLY IN RECESS DUE TO COVID-19
Title
A randomized, double-blind, parallel-group, multicenter study to assess efficacy, safety, and tolerability of oral tropifexor (LJN452) & licogliflozin (LIK066) combination therapy, compared to each monotherapy, for treatment of adult patients with nonalcoholic steatohepatitis (NASH) (ELIVATE)
Area
Liver
Indication
Current diagnosis of fatty liver disease with fibrosis
Treatment
Oral medication for NASH
Notify
Malana Kanallakan
314- 328-6466
University of Missouri Healthcare
The primary objective of the study is to evaluate safety and efficacy of ELAD with respect to overall survival of subjects with a clinical diagnosis of alcohol-induced liver decompensation (AILD) through at least Study Day 91.
Contact Susan Pew, RN Study Coordinator for more information.
Phone: 573-882-4758
Email: pews@health.missouri.edu
The Missouri Health Department has created an online tool for adding/updating information to the Missouri Viral Hepatitis Resource Directory. The goal is for the directory to provide a comprehensive list of all entities providing hepatitis related services.
To access the directory, click here.
Last updated on April 15th, 2024 at 09:20 am